+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Animal Medication - Global Strategic Business Report

  • PDF Icon

    Report

  • 284 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 2228005

Global Animal Medication Market to Reach $45.9 Billion by 2030

The global market for Animal Medication estimated at US$32.1 Billion in the year 2022, is projected to reach a revised size of US$45.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2022-2030. Companion Animals, one of the segments analyzed in the report, is projected to record 4.8% CAGR and reach US$20.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Cattle Farm Animals segment is readjusted to a revised 3.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $8.7 Billion, While China is Forecast to Grow at 7.7% CAGR

The Animal Medication market in the U.S. is estimated at US$8.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$9.8 Billion by the year 2030 trailing a CAGR of 7.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 3.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.

Select Competitors (Total 63 Featured) -

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Dechra Pharmaceuticals Plc.
  • Eli Lilly and Company
  • Merck Animal Health
  • Vetericyn Inc.
  • Vétoquinol SA
  • Virbac SA
  • Zoetis Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Animal Medication

What is the estimated value of the Global Market for Animal Medication?

The Global Market for Animal Medication was estimated to be valued at $32.1 Billion in 2022.

What is the growth rate of the Global Market for Animal Medication?

The growth rate of the Global Market for Animal Medication is 4.6%, with an estimated value of $45.9 Billion by 2030.

What is the forecasted size of the Global Market for Animal Medication?

The Global Market for Animal Medication is estimated to be worth $45.9 Billion by 2030.

Who are the key companies in the Global Market for Animal Medication?

Key companies in the Global Market for Animal Medication include Bayer AG, Boehringer Ingelheim International GmbH, Ceva Santé Animale S.A., Dechra Pharmaceuticals Plc., Eli Lilly and Company, Merck Animal Health, Vetericyn Inc., Vétoquinol SA, Virbac SA and Zoetis Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Importance of Animal Health: A Prelude
  • Common Diseases in Companion Animals
  • Recent Market Activity
  • Growing Demand for Animal Protein and Rising Pet Ownership Drives Animal Medication Market
  • Recent FDA Approved Animal Medication: 2018
  • Industry Dynamics
  • Developed Regions Ahead; Developing Markets Gathering Momentum
  • Farm Animals - The Largest Market Category
  • Parasiticides Stay in the Lead
  • Veterinary Vaccines Drive Market Growth
  • Anti-Infectives: Also a Significant Market Segment
  • Animal Medication - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • Bayer AG (Germany)
  • Boehringer Ingelheim International GmbH (Germany)
  • Ceva Santé Animale S.A. (France)
  • Dechra Pharmaceuticals PLC (UK)
  • Eli Lilly and Company (USA)
  • Merck Animal Health (Netherlands)
  • Vetericyn, Inc. (USA)
  • Vétoquinol SA (France)
  • Virbac SA (France)
  • Zoetis, Inc. (USA)
3. MARKET TRENDS & DRIVERS
  • Growing Pet Ownership and Spending Drives Demand
  • Companion Animals: A High Value Lucrative Market Segment
  • Need to Reduce the Foot Print of Food Production Drives Gains
  • Spread of Zoonotic Diseases Propels Growth
  • Unmet Animal Health Needs Drives Growth
  • Need to Ensure Sustainable Food Supply Spurs Growth
  • Increasing Demand for Animal Protein in Developing Countries to Benefit the Market
  • Opportunity Indicators
  • Growing Trend of Human Drug Pharmacies Dispensing Veterinary Medications
  • Flavored Veterinary Medications Registers NoTable Growth
  • Safety Concerns: An Opportunity Generator
  • Healthy Investments in Veterinary Pharmaceuticals Drive Growth
  • Role of Pharmacokinetics in Animal Drug Development
  • Animal Health Market Expected to Gain from Antimicrobial Resistance
  • Responsible use of Animal Medicines Ignites Interest in Herbal Alternatives
  • Will the Growing Support for Hormone and Antibiotic Free Animal Produce Impact the Growth Prospects of the Animal Medicine?
  • Veterinarians Loose Share to New Channels
  • Exclusive Animal Drugs Foray into Human Pharmacies
  • Rising ‘Gray' Market Sales for Animal Health Drugs
  • Growing Momentum for Post Slaughter Strategies Bodes well for Animal Medicine
  • Demand for Metabolic Modifiers Surging
  • Genomics to Influence Development of Animal Medicine in the Future
  • Nanotechnology Fast Gaining Ground in Animal Medicine
  • Animal Drug Distribution and Dispensing Sees Transformation - A Growing Threat to Veterinarians
  • Generic Insurgency in Animal Health Market - Not As Strong As in Human Health
  • Human Drugs Continue to Permeate Animal Drug Market, Manufacturers Queue in to Capitalize on Growing Prospects
  • Managing a Portfolio of Drugs - Key to Business Risk Aversion
  • Aquaculture Medicines - A Growing Niche in the Animal Medication Market
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Animal Medication Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Animal Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 3: World Historic Review for Animal Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 4: World 16-Year Perspective for Animal Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 6: World Historic Review for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 7: World 16-Year Perspective for Companion Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Cattle Farm Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 9: World Historic Review for Cattle Farm Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 10: World 16-Year Perspective for Cattle Farm Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Pigs Farm Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 12: World Historic Review for Pigs Farm Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 13: World 16-Year Perspective for Pigs Farm Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Other Categories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 15: World Historic Review for Other Categories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 16: World 16-Year Perspective for Other Categories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Parasiticides by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 18: World Historic Review for Parasiticides by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 19: World 16-Year Perspective for Parasiticides by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 21: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 22: World 16-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Anti-Infectives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 24: World Historic Review for Anti-Infectives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 25: World 16-Year Perspective for Anti-Infectives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Medicinal Feed Additives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 27: World Historic Review for Medicinal Feed Additives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 28: World 16-Year Perspective for Medicinal Feed Additives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 29: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 30: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 31: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Animal Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
CANADA
JAPAN
  • Animal Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
CHINA
  • Animal Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
EUROPE
  • Animal Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
FRANCE
  • Animal Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
GERMANY
  • Animal Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
ITALY
UNITED KINGDOM
  • Animal Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Animal Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
AUSTRALIA
  • Animal Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Animal Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Animal Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Animal Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Animal Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Dechra Pharmaceuticals Plc.
  • Eli Lilly and Company
  • Merck Animal Health
  • Vetericyn Inc.
  • Vétoquinol SA
  • Virbac SA
  • Zoetis Inc.